Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline

Individuals with prodromal Alzheimer’s disease show considerable variability in rates of cognitive decline, which hampers the ability to detect potential treatment effects in clinical trials. Prognostic markers to select those individuals who will decline rapidly within a trial time frame are needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelkmans, Wiesje, Vromen, Ellen M., Dicks, Ellen, Scheltens, Philip, Teunissen, Charlotte E., Barkhof, Frederik, van der Flier, Wiesje M., Tijms, Betty M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924646/
https://www.ncbi.nlm.nih.gov/pubmed/35310828
http://dx.doi.org/10.1093/braincomms/fcac026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924646/
https://www.ncbi.nlm.nih.gov/pubmed/35310828
http://dx.doi.org/10.1093/braincomms/fcac026

Ejemplares similares